Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-09 · accession 0001209191-23-018042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-10 | 2023-03-09 | TMCI | Scanlan Sean F. | Chief Innovation Off | S - Sale | $24.41 | -505 | 9,470 | -5% | -$12.3K |
| D | 2023-03-10 | 2023-03-10 | TMCI | Scanlan Sean F. | Chief Innovation Off | A - Grant | $0.00 | +22.9K | 32.4K | +242% | $0 |
| D | 2023-03-10 | 2023-03-10 | TMCI | Scanlan Sean F. | Chief Innovation Off | A - Grant | $0.00 | -52.0K | 52.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-09 | S | D | 505 | $24.41 | 9,470 | D | — | — | (F2) Includes 8,331 RSUs. |
| 2 | Common | Common Stock | 2023-03-10 | A | A | 22,925 | $0.00 | 32,395 | D | — | — | (F3) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. (F4) Includes 31,256 RSUs. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-03-10 | A | D | 51,950 | $0.00 | 51,950 | D | $24.07 · — to 2033-03-10 | 51,950 Stock Option (Right to Buy) | (F5) The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. |